Antibacterials Part 1 Flashcards

1
Q

What is prontosil converted to? Why is this important?

A

Prontosil was not actually the compound affecting bacteria, the derivative sulfanilamide was the causative compound. Conveniently, prontosil is converted to sulfanilamide by the bacteria in the GI tract, not by
the agent being targeted. Sulfanilamide can then enter the blood stream and subsequently travel to different parts of the body where it can reach the site of infection. This is an example of a pro-drug: drug is given in the inactive form and is converted to the active form in the body. The concept of a prodrug has been used in many drug situations. Currently the concept is being used to more selectively target cancer cells. If you could find something that is present in cancerous cells, but absent in normal cells, that could alter an inactivedrug into the active form, then you could selectively kill those cells with the ability to convert it.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the phases observed when bacteria are grown in culture. Why do these phases occur?

A

Bacteria grown in culture have 3 phases of growth. First is a lag phase:
bacteria were taken from a culture where they had previously reached the
stationary phase, basically non-growing, so there is going to be a lag phase before they are able to grow. They all of a sudden have access to excess nutrients,but it takes a while for them to take them up and incorporate them into biomolecules. After the lag they grow exponentially until eventually hitting the stationary phase. Stationary phase is a combination of running out of essential metabolites as well as producing toxic material, some of which may lower the pH of the media. And so theyll sit there until the waste is removed and they getmore nutrients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How can one tell that sulfanilamides are bacteriostatic rather than bacteriocidal?

A

Sulfanilamide mimics the basic growth curve in that there is a lag and log phase, but it plateaus out at a lower number of bacteria that you acheive without the drug. This indicates that the sulfanilamide is not directly causing bacterial killing, basically the growth is stopped after a lag period of time.
Suggests that something is being depleted that the organisms need in order to grow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

History of sulfanilamides

A

Gerhard Domagk demonstrated in 1933 that prontosil protected mice and rabbits against lethal doses of Staphylococus and Streptococcus bacteria (Awarded Nobel prize in 1939)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why should you not use a bacteriostatic drug if you have an immune deficiency?

A

Sulfanilamides target is dihydrofolate synthase. Dihydrofolate synthase is necessary to make thymidine. Sulfanilamides are bacteriostatic. If you have an immune deficiency, taking a bacteriostatic drug wont buy you much time. You need your immune system to wipe them out, so even if you stop them from growing for a period of time, once the drug is cleared from your system theyll start to proliferate again. This is assuming that other bacteria in your body have not eliminated/ outcompeted them. So dont use a bacteriostatic drug if you have an immune deficiency, use a bacteriocidal one. Sulfanilamide is a DNA synthesis inhibitor (thymidine is one of the four bases used to make DNA), so this presents a potential problem…because our cells also need to syntehsize thymidine to allow for DNA synthesis to occur.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What allows sulfa drugs to inhibit the growth of bacteria and not eukaryotic cells?

A

Bacteria must synthesize PABA in order to form dihydrofolate and eventually tetrahydrofolate to carry all of the needed synthesis out for thymidine. We do not have dihydrofolate synthase and so it wont affect us at least in terms
of this mechanism. We acquire our folate through diet, and in part through
bacteria that inhabit our gut (they die and release folate). One problem
with some antibiotics is that if you eliminate too many of the bacteria
that we get folate from, then unless you’re getting a sufficient amount of
folate in the diet, you may develop a folate deficiency and see effects in
a decrease in DNA synthesis and other biosynthetic pathways that require
folate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How can it be beneficial to give a drug orally that is poorly absorbed in the gut?

A

Normally, when you a give a drug orally that is poorly absorbed in the gut, you don’t really think of that as very useful. However,when you have an infection in your colon, it could
actually be an advantage. So drugs listed to the top right that are very poorly absorbed (low to nonexistant half-life) can be used to treat GI and intestinal tract infections. Lets say however, that you have a skin
infection/ wound infection. Then a drug that is given topically is often useful such as sulfacetamide. Silver itself has antibacterial properties and is added to some sulfanilamides to create a combination effect
(2 antibacterialagents present). Generally silver is only included in topical ointments as it doesn’t readily get across membranes to be affective elsewhere.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some sulfanilamides that are absorbed and excreted rapidly?

A

Sulfisoxazole, sulfamethoxazole, and sulfadiazine. These can be used to treat systemic infections and can be taken orally.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is a sulfanilamide that is poorly absorbed and is active in the bowel lumen?

A

Sulfasalazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some sulfanilamides that are used topically?

A

Sulfacetamide and silver sulfadiazine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a sulfanilamide that is long-acting?

A

Sulfadoxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are some side effects and issues with sulfa drugs?

A

Deficiency in white blood cells (leukopenia). Deficiency in platelets
(thrombocytopenia). Aplastic anemia, where bone marrow stope producing red
blood cell precursors. What causes these is not well understood. These fall under the category of side effects known as idiosyncratic reactions, meaning that we have no idea what causes them. Crystalurea, some of the compounds can fall out of solution in urine and form crystals. this can cause kidney damage, fortunately most sulfa drugs dont do this. Sulfa drugs bind to albumin, and will compete with albumin binding to oral hypoglycemics, or warfarin type drugs. Phenytoin will also compete with the P5450 isozymes that metabolize the sulfa drugs, so theres potential for drug-drug interactions. Additionally there are some allergic reactions that can occur: stevens-johnsons syndrome (blisters all over the body), toxic epidermal megalolysis, exfoliative dermatitis (skin sheds off the body).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What’s a genetic condition that can create problems when combined with sulfa drugs?

A

Genetic condition: Glucose-6-Phosphate Dehydrogenase deficiency. This enzyme is used in glycolysis and the pentose phosphate pathway. Problem comes with the pentose-phosphate pathway. Among the products produced in this pathway, is a reducing agent (NADPH). This product is especially important in our red blood cells. NADPH is used to reduce glutathione. So glutathione is very important in terms of overcoming oxidizing agent, so its a protective agent. The specific issue is that in red blood cells,
there is glutathione peroxidase which utilizes glutathione. Necessary for converting hydrogen peroxide to water. If there starts to become an accumulation of hydrogen peroxide in red blood cells, then hemoglobin starts to get damaged which subsequently leads to the formation of reactive oxygen species which work to create membrane damage. So individuals
with this defect dont express high enough levels of G6P which results in this chain of events leading to membrane damage, resulting in lysis of red blood cells giving whats called hemolytic anemia. So if you have this genetic condition and take sulfa drugs, theyll basically make the situation worse. The hemolytic anemia is only going on if you have a lot of oxidizing agents. Sulfa drugs are oxidizing agents so it depletes the already low level of glutathione. Favabeans should be avoided as well if you have the disease and can result in
death via the hemolytic anemia. Condition is sometimes referred to as favism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What was the 1937 Elixir Sulfanilamide Incident?

A
  • A company marketing sulfanilamide made an elixir containing the drug resulting in the poisoning and death of ~ 100 individuals
  • The elixir consisting of sulfanilamide, raspberry syrup, and diethylglycol was marketed without testing by Massengil, the pharmaceutical manufacturer (the pharmacist who did this committed suicide)
  • Led to the 1938 Food, Drug, and Cosmetic Act, which required that companies perform animal safety tests on drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What do sulfa drugs bear resemblance to and how does this dictate their MOA?

A

Sulfanilamides bear a resemblance to PABA. PABA is one of the building blocks in the biosynthetic pathway to forming tetrahydrofolate. Tetrahydrofolate is a major methyl group donor that is necessary for purine synthesis, generation of amino acids such as methionine, but most importantly, it is essential to forming the base thymidine, which is necessary to form ATP, which is necessary to power DNA synthesis. Given that sulfanilamide and PABA are sturcturally similar, it was easy to propose that sulfanilamide simply competes with PABA in the synthesis of tetrahydrofolate. However, it needed to be proven.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How was it proven that sulfa drugs compete with PABA?

A

This suggests competitive competition between PABA and sulfanilamide, and non-competitive competition between folate and sulfanilamide. This is because formation of folate is downstream of where sulfanilamide exerts its effects. This shows that with the addition of sulfanilamide, more and more PABA is needed
to maintain 50% of maximal growth of bacteria. Showed that sulfanilamide inhibited the conversion of PABA to folate.

17
Q

How do you test for G6P deficiency?

A

To test for G6P genetic deficiency, take a smear of blood and test with a number of dyes that will recognize what are known as hines bodies. These are inclusions of hemoglobin. These are very large and very distinct. This does not prove that you have this particular genetic deficiencies because plenty of things can lead to hemolytic anemia, but it suggests that its one of
the possibilities.

18
Q

What are some other uses besides antibiotic activity for sulfa drugs?

A

Sulfa drugs have many other activities discovered accidently after long term use of the drugs as antimicrobial agents: They have diuretic activity. Not a commonly used diuretic.
They also have antimalarial activity.
Also have oral hypoglycemic activity. Some currently used
oral hypoglycemics are derivatives of sulfonamindes.
Also have anti-mitotic activity. They have been used in the past as
cancer therapeutics. this requires a much higher level of drug
for it to be therapeutic in this instance, compared to the much
lower dosage needed to see only the antibacterial effects.

19
Q

Trimethoprim

A

Trimethoprim
-Structurallyrelatedtosulfonamides
-Inhibits bacterial dihydrofolate reductase (enzyme is also present in humans); bacteriostatic. Downstream of the target for sulfanilamide’s.
IC50 for the bacterial enzyme = 0.005 μM; IC50 for the human enzyme = 260 μM; (~50,000 fold difference). This gives rise to a safe therapeutic index.
-Long term use can cause megaloblastic anemia due to folate deficiency (can reverse this effect with folinic acid)
-Currently used in combination with sulfamethoxazole “trimethoprim-sulfa” or SXT. Commonaly prescribed for urinary tract infections.
-Effective in the treatment of Pneumocystis carinii
infection and Toxoplasmosis. Parasite that normally affects cats. Spreads fecally, and can cause birth defects.

20
Q

What is pneumocystis pneumonia associated with?

A

Pneumocystis pneumonia is associated with AIDS. Prior to the AIDS epidemic, human pneumocystis pneumonia infections were unheard of, but with AIDS patients, they have a comprimised
immune system, so it can infect them more readily.

21
Q

At what doses does trimethoprim have antibacterial activity?

A

At lower doses, Trimethoprim only inhibits the bacterial dihydrofolate reductase, so as long as you stay
within the therapeutic range its a selective drug as an antibacterial as opposed to generally blocking
cell growth.

22
Q

Do sulfanilamides and trimethoprim work at the same strip of the thymidylate synthesis pathway? Why is this important?

A

they work at two different steps in
the pathway. Explains why you get a more potent effect with a combination of antibacterial agents that target different parts of the pathway. Using a combination allows you to use each antibiotic at a lower concentration which reduces the side effects
and riskiness of the drugs.

23
Q

What is the MOA of fluoroquinolones?

A

Fluoroquinolones MOA: They target topoisomerase II. This is involved in two processes, one is relieving supercoiling. The other is decatination. The latter is the important step because
if decatination doesnt occur, the cell will still separate their DNA when division, however there are consequences. The only way to separate the DNA without decatination is to literally break
the DNA. Any time you have double strand breaks there are repair mechanisms, primarily homologous recombination in bacteria. These dont always work though, so the idea is that you
end up killing the cell via the creation of double stranded breaks and DNA damage. This is an example of a drug that targets both eukaryotes and prokaryotes, but there is a difference in
binding affinity that is sufficient to give a fairly high therapeutic index. If you do take too much though you will end up inhibiting your own topoisomerase.

24
Q

What are fluoroquinolones?

A

Fluoroquinolones
-Nalidixicacidderivatives. Not involved in thymidine synthesis pathway, but they are DNA synthesis inhibitors. These are DNA gyrase inhibitors. Gyrase is a topoisomerase II. It has two effects: removes positive supercoils ahead of DNA pol which
reduces the nubmer of supercoils, and it also is necessary for the decatination (separation of newly synthesized molecules). Both of these mechanisms may contribute to the effects of the drug. This drug is bacteriocidal. The cells will divide, and one of the cells will have either the two DNA molecules still intercalated together, while the other cell will have no DNA. As a result, you end up with cell killing. Carries the risk of killing off the harmless normal flora of the body, especially if taken for a long time. This can lead to yeast infections because the normal flora
help to keep fungal infections in check through competition.
-Example:Ciprofloxacin“Cipro”
We also have topoisomerase II, but there is a large therapeutic index separating the effects on bacterial cells vs the effects on eukaryotic cells.

25
Q

What are some adverse effects if fluoroquinolones?

A

Adverse Effects
Insomnia,confusion,headaches,dizziness, anxiety, photosensitivity (limit sunlight exposure to skin).
- Inhibits caffeine metabolism (lay off the caffeine).
- Damage to cartilage reported in animal studies (doesn’t appear to be an issue in humans yet).
-Cipro and Warfarin compete for same P450 isozyme (drug-drug interaction. Leads to potential for excess bleeding.

26
Q

What are phase IV studies? Why are they needed?

A

The Need for “Phase IV” Clinical Studies
- Temafloxacin approved forclinical use in 1992
- Subsequently withdrawn due to rare but serious side effects including anaphylaxis, liver failure, hemolytic anemia, renal failure, death
- Incidence of serious adverse effects~1/3500. Phase III trials involved 4000 individuals. Phase IV: not required for licensing for widespread use, but usually companies are asked to report
adverse side effects in the longterm and high population pools. Can show rare effects.